Activation of the P38/CREB/MMP13 Axis is Associated with Osteoarthritis

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2019 Jul 17

PMID 31308631

Citations 23

Authors

Bin Ji

Yan Ma

Haimin Wang

Xiangqian Fang

Peihua Shi

Affiliations

Soon will be listed here.

Abstract

Purposes: Osteoarthritis (OA) is a common joint disease characterized by the degradation of articular cartilage and joint inflammation. Interleukin-1ß induces P38/cAMP response element binding protein (CREB) pathway activation, resulting in increased expression of matrix metallopeptidase-13 (MMP13) in chondrocytes. However, the role of the P38/CREB/MMP13 axis is unclear in the progression of OA. In this study, we aimed to answer the following questions: (1) how does the P38/CREB/MMP13 axis in cartilage from patients with OA compare with control specimens? (2) Can the P38 agonist anisomycin (ANS) induce mouse OA?

Materials And Methods: Surgical specimens of human cartilage were divided into OA and control groups. Surgical specimens of mouse cartilage were divided into control and ANS-induced groups. Safranin O staining of the cartilage tissues was performed to evaluate the extracellular matrix. Reverse transcription-polymerase chain reaction was performed using these tissues to investigate messenger RNA expressions of type II collagen, aggrecan, MMP13, and ADAM metallopeptidase with thrombospondin type 1 motif 5. Phosphorylated (p)-P38, p-CREB, and MMP13 were evaluated by Western blot analysis. Anisomycin was used to activate P38, and p-P38, p-CREB, and MMP13 were evaluated by immunofluorescence and Western blot analysis.

Results: Safranin O staining showed that the extracellular matrix degraded in humans with OA and ANS-induced mouse cartilage samples. The expressions of p-P38, p-CREB, and MMP13 were all upregulated in osteoarthritic cartilage or anisomycin-induced chondrocytes, suggesting that the P38/CREB/MMP13 axis may play a role in the progression of OA.

Conclusions: The P38/CREB/MMP13 axis is active in osteoarthritic chondrocytes and may cause the degeneration of cartilage. Effective new therapy directed against this pathway could be developed.

Citing Articles

Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway.

Ning J, Chen X, Li Q, Yang D, Xie C, Qin S Sci Rep. 2024; 14(1):24233.

PMID: 39414944 PMC: 11484833. DOI: 10.1038/s41598-024-75089-7.

Blocking IL-33 decelerates cartilage degeneration in knee osteoarthritis through mice model.

Wu F, Zhang S, Zhuang R, Hu C, Zhu K PLoS One. 2024; 19(8):e0301199.

PMID: 39172956 PMC: 11340949. DOI: 10.1371/journal.pone.0301199.

Clinical Outcome of Multiple Platelet-Rich Plasma Injection and Correlation with PDGF-BB in the Treatment of Knee Osteoarthritis.

Partan R, Putra K, Hafizzanovian H, Darma S, Reagan M, Muthia P J Pers Med. 2024; 14(2).

PMID: 38392616 PMC: 10890090. DOI: 10.3390/jpm14020183.

Glycolysis: an emerging regulator of osteoarthritis.

Jiang D, Guo J, Liu Y, Li W, Lu D Front Immunol. 2024; 14:1327852.

PMID: 38264652 PMC: 10803532. DOI: 10.3389/fimmu.2023.1327852.

The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression.

Wang Y, Wu Z, Yan G, Li S, Zhang Y, Li G Bone Joint Res. 2024; 13(1):4-18.

PMID: 38163445 PMC: 10758301. DOI: 10.1302/2046-3758.131.BJR-2023-0016.R2.

References

Frost R, Nystrom G, Lang C . Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway. Endocrinology. 2000; 141(9):3156-64. DOI: 10.1210/endo.141.9.7641. View

Vincenti M, Brinckerhoff C . Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002; 4(3):157-64. PMC: 128926. DOI: 10.1186/ar401. View

Kobayashi M, Squires G, Mousa A, Tanzer M, Zukor D, Antoniou J . Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005; 52(1):128-35. DOI: 10.1002/art.20776. View

Aida Y, Maeno M, Suzuki N, Shiratsuchi H, Motohashi M, Matsumura H . The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sci. 2005; 77(25):3210-21. DOI: 10.1016/j.lfs.2005.05.052. View

Shafer L, Slice L . Anisomycin induces COX-2 mRNA expression through p38(MAPK) and CREB independent of small GTPases in intestinal epithelial cells. Biochim Biophys Acta. 2005; 1745(3):393-400. DOI: 10.1016/j.bbamcr.2005.07.002. View

Burrage P, Mix K, Brinckerhoff C . Matrix metalloproteinases: role in arthritis. Front Biosci. 2005; 11:529-43. DOI: 10.2741/1817. View

Roach H, Yamada N, Cheung K, Tilley S, Clarke N, Oreffo R . Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005; 52(10):3110-24. DOI: 10.1002/art.21300. View

Pritzker K, Gay S, Jimenez S, Ostergaard K, Pelletier J, Revell P . Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2005; 14(1):13-29. DOI: 10.1016/j.joca.2005.07.014. View

Smith Jr G . The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis. Front Biosci. 2006; 11:3081-95. DOI: 10.2741/2034. View

10.

Ross S, Chen T, Yu V, Tudor Y, Zhang D, Liu L . High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays. Assay Drug Dev Technol. 2006; 4(4):397-409. DOI: 10.1089/adt.2006.4.397. View

11.

Funding A, Johansen C, Kragballe K, Iversen L . Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis. J Invest Dermatol. 2007; 127(8):2012-9. DOI: 10.1038/sj.jid.5700821. View

12.

Thalhamer T, McGrath M, Harnett M . MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford). 2008; 47(4):409-14. DOI: 10.1093/rheumatology/kem297. View

13.

Gosset M, Berenbaum F, Thirion S, Jacques C . Primary culture and phenotyping of murine chondrocytes. Nat Protoc. 2008; 3(8):1253-60. DOI: 10.1038/nprot.2008.95. View

14.

Zayed N, Afif H, Chabane N, Mfuna-Endam L, Benderdour M, Martel-Pelletier J . Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2. Arthritis Rheum. 2008; 58(11):3530-40. PMC: 2657141. DOI: 10.1002/art.23958. View

15.

Kanwar J, Kanwar R, Burrow H, Baratchi S . Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem. 2009; 16(19):2373-94. DOI: 10.2174/092986709788682155. View

16.

Joos H, Albrecht W, Laufer S, Brenner R . Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1beta-stimulated human chondrocytes. Br J Pharmacol. 2010; 160(5):1252-62. PMC: 2936033. DOI: 10.1111/j.1476-5381.2010.00760.x. View

17.

Shiomi T, Lemaitre V, DArmiento J, Okada Y . Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int. 2010; 60(7):477-96. PMC: 3745773. DOI: 10.1111/j.1440-1827.2010.02547.x. View

18.

Haq S, Davatchi F, Dahaghin S, Islam N, Ghose A, Darmawan J . Development of a questionnaire for identification of the risk factors for osteoarthritis of the knees in developing countries. A pilot study in Iran and Bangladesh. An ILAR-COPCORD phase III study. Int J Rheum Dis. 2010; 13(3):203-14. DOI: 10.1111/j.1756-185X.2010.01529.x. View

19.

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J, Fahmi H . Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):33-42. DOI: 10.1038/nrrheum.2010.196. View

20.

Kinds M, Welsing P, Vignon E, Bijlsma J, Viergever M, Marijnissen A . A systematic review of the association between radiographic and clinical osteoarthritis of hip and knee. Osteoarthritis Cartilage. 2011; 19(7):768-78. DOI: 10.1016/j.joca.2011.01.015. View